<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00180000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P29274</UniProt_ID>
  <Seq_Length>412</Seq_Length>
  <Molecule_Weight>44707</Molecule_Weight>
  <KEGG_ID>hsa:135</KEGG_ID>
  <Orthology_ID>K04266</Orthology_ID>
  <EBI_ID>EBI-2902702</EBI_ID>
  <Function_Summary>Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>7</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>A2 A adenosine receptor</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any enzyme.</Detail>
      <Keyword>Enzyme binding</Keyword>
      <Ontology_ID>GO:0019899</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>300</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>50</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>392</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An endocytosis process that results in the engulfment of external particulate material by phagocytes. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.</Detail>
      <Keyword>Phagocytosis</Keyword>
      <Ontology_ID>GO:0006909</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive a sensory stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.</Detail>
      <Keyword>Sensory perception</Keyword>
      <Ontology_ID>GO:0007600</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A defense response that is mediated by cells.</Detail>
      <Keyword>Cellular defense response</Keyword>
      <Ontology_ID>GO:0006968</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).</Detail>
      <Keyword>CAMP biosynthetic process</Keyword>
      <Ontology_ID>GO:0006171</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of the nerve growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Nerve growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048011</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS</Protein_Seq>
    <DNA_Seq>GGCACGAGGCTGGCTGAGCCATGATGCTGCTGCCAGAACCCCTGCAGAGGGCCTGGTTTCAGGAGACTCAGAGTCCTCTGTGAAAAAGCCCTTGGAGAGGCGCCCCAGCAGGGCTGCACTTGGCTCCTGTGAGGAAGGGGCTCAGGGTCTGGGCCCCTCCGCCTGGGCCGGGCTGGGAGCCAGGCGGGCGGCTGGGCTGCAGCAATGGACCGTGAGCTGGCCCAGCCCGCGTCCGTGCTGAGCCTGCCTGTCGTCTGTGGCCATGCCATCATGGGCTCCTCGGTGTACATCACGGTGGAGCTGGCCATTGCTGTGCTGGCCATCCTGGGCAATGTGCTGGTGTGCTGGGCCGTGTGGCTCAACAGCAACCTGCAGAACGTCACCAACTACTTTGTGGTGTCACTGGCGGCGGCCGACATCGCAGTGGGTGTGCTCGCCATCCCCTTTGCCATCACCATCAGCACCGGGTTCTGCGCTGCCTGCCACGGCTGCCTCTTCATTGCCTGCTTCGTCCTGGTCCTCACGCAGAGCTCCATCTTCAGTCTCCTGGCCATCGCCATTGACCGCTACATTGCCATCCGCATCCCGCTCCGGTACAATGGCTTGGTGACCGGCACGAGGGCTAAGGGCATCATTGCCATCTGCTGGGTGCTGTCGTTTGCCATCGGCCTGACTCCCATGCTAGGTTGGAACAACTGCGGTCAGCCAAAGGAGGGCAAGAACCACTCCCAGGGCTGCGGGGAGGGCCAAGTGGCCTGTCTCTTTGAGGATGTGGTCCCCATGAACTACATGGTGTACTTCAACTTCTTTGCCTGTGTGCTGGTGCCCCTGCTGCTCATGCTGGGTGTCTATTTGCGGATCTTCCTGGCGGCGCGACGACAGCTGAAGCAGATGGAGAGCCAGCCTCTGCCGGGGGAGCGGGCACGGTCCACACTGCAGAAGGAGGTCCATGCTGCCAAGTCACTGGCCATCATTGTGGGGCTCTTTGCCCTCTGCTGGCTGCCCCTACACATCATCAACTGCTTCACTTTCTTCTGCCCCGACTGCAGCCACGCCCCTCTCTGGCTCATGTACCTGGCCATCGTCCTCTCCCACACCAATTCGGTTGTGAATCCCTTCATCTACGCCTACCGTATCCGCGAGTTCCGCCAGACCTTCCGCAAGATCATTCGCAGCCACGTCCTGAGGCAGCAAGAACCTTTCAAGGCAGCTGGCACCAGTGCCCGGGTCTTGGCAGCTCATGGCAGTGACGGAGAGCAGGTCAGCCTCCGTCTCAACGGCCACCCGCCAGGAGTGTGGGCCAACGGCAGTGCTCCCCACCCTGAGCGGAGGCCCAATGGCTATGCCCTGGGGCTGGTGAGTGGAGGGAGTGCCCAAGAGTCCCAGGGGAACACGGGCCTCCCAGACGTGGAGCTCCTTAGCCATGAGCTCAAGGGAGTGTGCCCAGAGCCCCCTGGCCTAGATGACCCCCTGGCCCAGGATGGAGCAGGAGTGTCCTGATGATTCATGGAGTTTGCCCCTTCCTAAGGGAAGGAGATCTTTATCTTTCTGGTTGGCTTGACCAGTCACGTTGGGAGAAGAGAGAGAGTGCCAGGAGACCCTGAGGGCAGCCGGTTCCTACTTTGGACTGAGAGAAGGGAGCCCCAGGCTGGAGCAGCATGAGGCCCAGCAAGAAGGGCTTGGGTTCTGAGGAAGCAGATGTTTCATGCTGTGAGGCCTTGCACCAGGTGGGGGCCACAGCACCAGCAGCATCTTTGCTGGGCAGGGCCCAGCCCTCCACTGCAGAAGCATCTGGAAGCACCACCTTGTCTCCACAGAGCAGCTTGGGCACAGCAGACTGGCCTGGCCCTGAGACTGGGGAGTGGCTCCAACAGCCTCCTGCCACCCACACACCACTCTCCCTAGACTCTCCTAGGGTTCAGGAGCTGCTGGGCCCAGAGGTGACATTTGACTTTTTTCCAGGAAAAATGTAAGTGTGAGGAAACCCTTTTTATTTTATTACCTTTCACTCTCTGGCTGCTGGGTCTGCCGTCGGTCCTGCTGCTAACCTGGCACCAGAGCCTCTGCCGGGGAGCCTCAGGCAGTCCTCTCCTGCTGTCACAGCTGCCATCCACTTCTCAGTCCCAGGGCCATCTCTTGGAGTGACAAAGCTGGGATCAAGGACAGGGAGTTGTAACAGAGCAGTGCCAGAGCATGGGCCCAGGTCCCAGGGGAGAGGTTGGGGCTGGCAGGCCACTGGCATGTGCTGAGTAGCGCAGAGCTACCCAGTGAGAGGCCTTGTCTAACTGCCTTTCCTTCTAAAGGGAATGTTTTTTTCTGAGATAAAATAAAAACGAGCCACATCGTGTTTTAAGCTTGTCCAAATGAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Blood vessels</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ADORA2A</Gene_Name>
    <Gene_Alias>ADORA2</Gene_Alias>
    <Gene_ID>135</Gene_ID>
    <Genbank_ACCN>NM_000675</Genbank_ACCN>
    <Protein_ACCN>NP_000666</Protein_ACCN>
    <HGNC_ID>263</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/135</Gene_URL>
    <UCSC_ID>uc002zzx.3</UCSC_ID>
    <EMBL_ID>ENSG00000128271</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P14416</Uniprot_ID>
      <Gene_Name>DRD2</Gene_Name>
      <EBI_ID>EBI-2928178</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-2928178</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P31424-1</Uniprot_ID>
      <Gene_Name>Grm5</Gene_Name>
      <EBI_ID>EBI-2902778</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-2902778</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13107</Uniprot_ID>
      <Gene_Name>USP4</Gene_Name>
      <EBI_ID>EBI-723290</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-723290</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P30542</Uniprot_ID>
      <Gene_Name>ADORA1</Gene_Name>
      <EBI_ID>EBI-2903663</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-2903663</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q7Z6G3</Uniprot_ID>
      <Gene_Name>NECAB2</Gene_Name>
      <EBI_ID>EBI-950070</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-950070</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P62158</Uniprot_ID>
      <Gene_Name>CALM3</Gene_Name>
      <EBI_ID>EBI-397435</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-397435</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q99418</Uniprot_ID>
      <Gene_Name>CYTH2</Gene_Name>
      <EBI_ID>EBI-448974</EBI_ID>
      <PPI_EBI_URL>EBI-2902702,EBI-448974</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Migraine with Aura</Disease_Name>
      <Disease_Detail>Migraine</Disease_Detail>
      <Disease_DB>MGR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/migraine_with_aura?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parkinson's Disease</Disease_Name>
      <Disease_Detail>Parkinson's Disease</Disease_Detail>
      <Disease_DB>PRK002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parkinsons_disease?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Huntington's Disease</Disease_Name>
      <Disease_Detail>Huntington's Disease</Disease_Detail>
      <Disease_DB>HNT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/huntingtons_disease?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Schizophrenia</Disease_Name>
      <Disease_Detail>Schizophrenia</Disease_Detail>
      <Disease_DB>SCH015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/schizophrenia?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ischemia</Disease_Name>
      <Disease_Detail>Ischemia</Disease_Detail>
      <Disease_DB>ISC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ischemia?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion</Disease_Name>
      <Disease_Detail>Acute Encephalopathy with Biphasic Seizures and Late Reduced Diffusion</Disease_Detail>
      <Disease_DB>ACT191</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_encephalopathy_with_biphasic_seizures_and_late_reduced_diffusion?search=ADORA2A#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385.</PDB_Title>
      <PDB_ID>3EML</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3EML</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.</PubMed_Title>
      <Author>Jaakola VP, et al.</Author>
      <Journal>Science. 2008 Nov 21;322(5905):1211-7.</Journal>
      <PubMed_ID>18832607</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 2.7 A resolution</PDB_Title>
      <PDB_ID>3VG9</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VG9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00180006</ASD_Ligand>
      <PubMed_Title>G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody</PubMed_Title>
      <Author>Hino, T., et al.</Author>
      <Journal>Nature(2012)482:237-240</Journal>
      <PubMed_ID>22286059</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 3.1 A resolution</PDB_Title>
      <PDB_ID>3VGA</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VGA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <ASD_Ligand>ASD00180006</ASD_Ligand>
      <PubMed_Title>G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody</PubMed_Title>
      <Author>Hino, T., et al.</Author>
      <Journal>Nature(2012)482:237-240</Journal>
      <PubMed_ID>22286059</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the chimeric protein of A2aAR-BRIL in complex with ZM241385 at 1.8A resolution</PDB_Title>
      <PDB_ID>4EIY</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4EIY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03160008</ASD_Ligand>
      <PubMed_Title>Structural basis for allosteric regulation of GPCRs by sodium ions.</PubMed_Title>
      <Author>Liu, W., et al.</Author>
      <Journal>Science(2012)337:232-236</Journal>
      <PubMed_ID>22798613</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04270</Pathway_ID>
      <Pathway_Title>Vascular smooth muscle contraction</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Circulatory system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05012</Pathway_ID>
      <Pathway_Title>Parkinson's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05034</Pathway_ID>
      <Pathway_Title>Alcoholism</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Substance dependence</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04015</Pathway_ID>
      <Pathway_Title>Rap1 signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_URL>http://www.cathdb.info/pdb/3eml</CATH_URL>
  </Fold>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00170297</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00170348</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00180008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>